AMINOSYN II 3.5% M
LOE Approachingamino acids; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic, heptahydrate
NDAINJECTIONINJECTABLE
Approved
Apr 1986
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 22h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AMINOSYN II 3.5% M is an injectable parenteral nutrition formulation containing amino acids, electrolytes (magnesium, potassium, sodium), and phosphate for intravenous administration. It is used to provide essential amino acids and electrolytes to patients unable to maintain adequate nutrition through oral or enteral routes, such as post-surgical patients, critically ill patients, or those with severe gastrointestinal dysfunction. The product works by delivering balanced amino acid profiles and critical minerals directly into the bloodstream to support protein synthesis and metabolic function.
LOE Approaching
As an established parenteral nutrition product approaching LOE with moderate competitive pressure (30), this represents a stable institutional/hospital-focused portfolio—expect defensive strategy and lean commercial teams focused on manufacturing excellence and hospital relationships.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on AMINOSYN II 3.5% M as a pharma professional means joining a stable, operations-centric team focused on manufacturing excellence, supply chain optimization, and hospital relationships rather than drug development or commercial expansion. Career trajectories emphasize technical skills in quality assurance, engineering, and procurement—ideal for professionals seeking operational stability over launch excitement.
Engineer
Worked on AMINOSYN II 3.5% M at ICU Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.